基因型-表型关系在多变性心肌病症
Dovilė Žebrauskienė1, Eglė Sadauskienė2, Roma Puronaitė2,3
1Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania.
Genes
|September 27, 2025
概括
遗传变异影响过度缩性心肌病 (HCM) 的呈现,导致更早的诊断和更严重的过度缩. 然而,基因型并不能预测HCM患者诊断后的临床结果.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 内部医学 内部医学
背景情况:
- 过度缩性心肌病 (HCM) 是一种遗传性心脏病,具有显著的遗传和表型变异性.
- 在HCM中基因型和临床过程之间的关系仍然不完全理解.
研究的目的:
- 研究被诊断患有HCM的患者的表型和分子特征.
- 评估病原性/可能病原性 (P/LP) 变体对HCM表现和临床过程的影响.
主要方法:
- 分析了2005年至2024年期间接受治疗的214名成年HCM患者的临床和遗传数据.
- 具有和没有确定的P/LP变体的患者之间的比较分析.
主要成果:
- 在43%的患者中,发现了致病性/可能致病性 (P/LP) 变体.
- 与没有确定的遗传原因相比,患有P/LP变异的个体被诊断得更早,并表现出更大的最大心脏缩.
- 患有P/LP变异的患者更早出现心房动,心室动脉冲动和心力衰竭.
结论:
- 基因型显著影响过度缩性心肌病变的表型,导致早期发病和增加过度缩.
- 一旦诊断出来,特定的基因型可能无法预测HCM的临床结果.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
411
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
411
Heart Failure II: Pathophysiology
730
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
730
Cardiomyopathy I: Introduction and Classification
504
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
504
Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Pathophysiology of Heart Failure
2.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.9K
Cardiomyopathy II: Dilated Cardiomyopathy
470
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
470


